SPHK1 and acute pancreatitis: Recently, expression of Sphk-1 and its activity were found to be markedly increased in peripheral immune cells of patients in the early stages of severe acute pancreatitis, indicating that the regulation of the Sphk-1 pathway may represent a novel target in the treatment of this disease (21).